Study design and participants
CUHNFT is a tertiary hospital in the UK with approximately 1,000 beds.
During the pandemic, wards were categorised as “red”, “amber” or
“green”. Patients with confirmed COVID-19 were cared for on red wards,
and patients who had negative SARS-CoV-2 tests and no clinical features
of COVID-19 on green wards. Patients awaiting test results, who had
clinical features of COVID-19 but a negative test result, or who may
have been exposed to SARS-CoV-2 were cared for on amber wards. RPE for
staff on red wards was changed from FRSMs to FFP3 respirators on
22/12/20. HCWs on green wards continued to wear FRSMs. HCWs on all wards
also wore eye protection.
A comprehensive PCR-based HCW screening programme is established at
CUHNFT, with symptomatic testing offered as required and asymptomatic
testing offered to all HCWs weekly [9, 12]. From 22/12/20,
twice-weekly swabbing was offered on red wards and on wards where the
most vulnerable patients were cared for. Cases were identified from a
database of all positive results, which additionally encompasses
positive results from community testing. This recorded the date of swab,
onset of symptoms (if present) and in which clinical area the HCW
worked.
The start of the study period was taken to be 02/11/20, coinciding with
an increase in community incidence of SARS-CoV-2 infection and formal
implementation of weekly asymptomatic screening for all staff members.
New infections on or prior to 27/12/20 were attributed to exposure
before the change in RPE. Infections detected later than this date were
attributed to exposure after the change in RPE. This timing was chosen
to reflect the median incubation period of SARS-CoV-2 (5.1 days), with
27/12/20 falling five days after the change in RPE [13, 14]. Since
staff testing was not conducted at weekends, eight complete weeks were
assessed in total prior to the change in RPE (Table 1).
A programme of SARS-CoV-2 vaccination using the BNT162b2 COVID-19
vaccine commenced at CUHNFT on 08/12/20 [15]. In line with UK
national guidance, the programme initially prioritised local residents
over the age of 80. However, some HCWs who had been identified as at
high risk from SARS-CoV-2 infection were also vaccinated, and were
additionally prevented from working on red wards. From 08/01/21 the
programme switched to vaccinating HCWs, with initial priority being
given to staff on red wards. To avoid the potential for confounding, the
end of the study period was therefore taken to be 15/01/21, since
minimal effect is expected in the first seven days after the first dose
of vaccine [16].
Because of the rising number of admissions to CUHNFT with COVID-19, the
number of red wards was increased from one at the beginning of November
2020 to seven by the week starting 11/01/21. Six wards therefore changed
from green to red during the period of data collection. Of 609 positive
results over the entire study period, 169 (27.8%) were included in this
study. Exclusions encompassed HCWs who were not ward-based or worked
between different wards with different red/amber/green status (269/609,
44.2% of positive results), HCW working on amber wards (9/609, 1.5%),
non-clinical staff (141/609, 23.1%), and staff working in critical care
areas (21/609, 3.5%), where different RPE was used throughout
(Table 1 ).
If a staff member tested positive within five days of their ward
changing colour, their case was classified according to the red/green
status of their ward five days before their positive test (to allow for
the incubation period, as above).